Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thisosulfate protection in ovarian cancer patients with either pathologically complete response or minimal disease

R.E.N. van Rijswijk, K. Hoekman, C.W. Burger, P. Kenemans, J.B. Vermorken

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1235-1241
JournalAnnals of Oncology
Volume8
DOIs
Publication statusPublished - 1997

Cite this